Morphologically Virus-Like Fullerenol Nanoparticles Act as the Dual-Functional Nanoadjuvant for HIV-1 Vaccine
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Morphologically Virus-Like Fullerenol Nanoparticles Act as the Dual-Functional Nanoadjuvant for HIV-1 Vaccine
Authors
Keywords
-
Journal
ADVANCED MATERIALS
Volume 25, Issue 41, Pages 5928-5936
Publisher
Wiley
Online
2013-08-21
DOI
10.1002/adma.201300583
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Surface-Engineered Gold Nanorods: Promising DNA Vaccine Adjuvant for HIV-1 Treatment
- (2012) Ligeng Xu et al. NANO LETTERS
- The induction of innate and adaptive immunity by biodegradable poly(γ-glutamic acid) nanoparticles via a TLR4 and MyD88 signaling pathway
- (2011) Tomofumi Uto et al. BIOMATERIALS
- Programming the magnitude and persistence of antibody responses with innate immunity
- (2011) Sudhir Pai Kasturi et al. NATURE
- Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine
- (2011) Scott G. Hansen et al. NATURE
- Polyhydroxy Fullerenes (Fullerols or Fullerenols): Beneficial Effects on Growth and Lifespan in Diverse Biological Models
- (2011) Jie Gao et al. PLoS One
- Binding of blood proteins to carbon nanotubes reduces cytotoxicity
- (2011) C. Ge et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- [Gd@C82(OH)22]n Nanoparticles Induce Dendritic Cell Maturation and Activate Th1 Immune Responses
- (2010) De Yang et al. ACS Nano
- Studies on anti-tumor and antimetastatic activities of fullerenol in a mouse breast cancer model
- (2010) Fang Jiao et al. CARBON
- Poly(Anhydride) Nanoparticles Act as Active Th1 Adjuvants through Toll-Like Receptor Exploitation
- (2010) I. Tamayo et al. Clinical and Vaccine Immunology
- Modulation of Gene Expression Related to Toll-Like Receptor Signaling in Dendritic Cells by Poly( -Glutamic Acid) Nanoparticles
- (2010) T. Hamasaki et al. Clinical and Vaccine Immunology
- Targeting early infection to prevent HIV-1 mucosal transmission
- (2010) Ashley T. Haase NATURE
- The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors
- (2010) Taro Kawai et al. NATURE IMMUNOLOGY
- Metallofullerene nanoparticles circumvent tumor resistance to cisplatin by reactivating endocytosis
- (2010) X.-J. Liang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Fullerene Nanoparticles Selectively Enter Oxidation-Damaged Cerebral Microvessel Endothelial Cells and Inhibit JNK-Related Apoptosis
- (2009) Fang Lao et al. ACS Nano
- The effect of Gd@C82(OH)22 nanoparticles on the release of Th1/Th2 cytokines and induction of TNF-α mediated cellular immunity
- (2009) Ying Liu et al. BIOMATERIALS
- Immunostimulatory properties and enhanced TNF- α mediated cellular immunity for tumor therapy by C60(OH)20nanoparticles
- (2009) Ying Liu et al. NANOTECHNOLOGY
- Attenuation of delayed-type hypersensitivity by fullerene treatment
- (2009) Keichiro Yamashita et al. TOXICOLOGY
- Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: Safety and immunogenicity of a phase 1/2 clinical trial
- (2009) Wendy Keitel et al. VACCINE
- The combination of stabilized plasmid lipid particles and lipid nanoparticle encapsulated CpG containing oligodeoxynucleotides as a systemic genetic vaccine
- (2008) Kaley D. Wilson et al. JOURNAL OF GENE MEDICINE
- Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans
- (2008) Troy D Querec et al. NATURE IMMUNOLOGY
- HIV Vaccine Research: The Way Forward
- (2008) A. S. Fauci et al. SCIENCE
- Non-viral gene transfection technologies for genetic engineering of stem cells
- (2007) Jun-ichiro Jo et al. EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started